These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18549939)

  • 41. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.
    Leiter LA; Martineau P; de Teresa E; Farsang C; Gaw A; Gensini G; Langer A;
    J Fam Pract; 2008 Oct; 57(10):661-8. PubMed ID: 18842192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: a nonrandomized study of the history of long-term statin treatment before coronary angioplasty.
    Miyagi M; Ishii H; Murakami R; Isobe S; Hayashi M; Amano T; Arai K; Ohashi T; Uetani T; Matsubara T; Murohara T
    Clin Ther; 2009 Jan; 31(1):64-73. PubMed ID: 19243707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
    Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
    Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Do Turkish reimbursement recommendations cover current European Lipid Guidelines? A retrospective analysis of patients presenting with first acute coronary syndrom].
    Demirci D; Ersan Demirci D; Esin M; Kayhan Ö; Arslan Ş
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):623-629. PubMed ID: 28990943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl.
    Kini AS; Muntner P; Moreno PR; Mann D; Krishnan P; Kim MC; Rafael OC; Farkouh ME; Sharma SK
    Am J Cardiol; 2009 Feb; 103(3):350-4. PubMed ID: 19166688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
    Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute coronary syndrome in 1366 patients at Siriraj Hospital: clinical characteristics, management and in-hospital outcomes.
    Tungsubutra W; Tresukosol D; Krittayaphong R; Panchavinnin P; Chotnaiwattarakul C; Phankingtongkhum R
    J Med Assoc Thai; 2007 Nov; 90 Suppl 2():25-32. PubMed ID: 19230422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
    Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
    Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CHD risk equivalents and the metabolic syndrome. Trial evidence supports aggressive management.
    Thompson PD
    Postgrad Med; 2003 Aug; 114(2 Suppl):22-30. PubMed ID: 19667636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia.
    Al Sifri S; Al Shammeri O; Al Jaser S; Alkhenizan A; Bin Shafi Shafiurrehman A; Morcos B; Wajih S; Elnahal I; Horack M; Brudi P; Lautsch D; Ambegaonkar B; Vyas A; Baxter CA; Gitt AK
    Saudi Med J; 2018 Jul; 39(7):697-704. PubMed ID: 29968891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Goal attainment in patients referred to a telephone-based dyslipidemia program.
    Palmieri J; Redline S; Morita R
    Am J Health Syst Pharm; 2005 Aug; 62(15):1586-91. PubMed ID: 16030368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention.
    Anderson TJ
    Can J Cardiol; 2015 May; 31(5):585-7. PubMed ID: 25936485
    [No Abstract]   [Full Text] [Related]  

  • 58. [The trends in clinical management of hyperlipidemia and goal attainment rate from 2000 to 2004 - 2006 in China].
    Zhao LC; Liang LR; Chen Z; Tian XZ; Wu YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):861-4. PubMed ID: 18070485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations].
    Mayer O; Mayer O
    Vnitr Lek; 2004 Oct; 50(10):777-80. PubMed ID: 15633934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study.
    Andrikopoulos G; Tzeis S; Nikas N; Richter D; Pipilis A; Gotsis A; Tsaknakis T; Kartalis A; Kitsiou A; Toli K; Mantas I; Olympios C; Pras A; Lampropoulos S; Oikonomou K; Pappas C; Kranidis A; Anastasiou-Nana M; Triposkiadis F; Goudevenos I; Theodorakis G; Vardas P
    Int J Cardiol; 2013 Sep; 168(2):922-7. PubMed ID: 23186596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.